MML Investors Services’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-125
Closed -$3.29K – 3287
2026
Q1
$3.29K Sell
125
-5
-4% -$629 ﹤0.01% 2994
2025
Q4
$32.1K Hold
130
– – ﹤0.01% 2996
2025
Q3
$27.2K Buy
+130
New +$22.9K ﹤0.01% 2869

Other funds holding GOSS

MML Investors Services's GOSS Position: Q2 2026 in Review

MML Investors Services sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 125 shares — an estimated $3.29K sold.

MML Investors Services first reported a position in GOSS in Q3 2025 and held it in 3 quarters. The position peaked at $32.1K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • MML Investors Services reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • MML Investors Services sold 125 Gossamer Bio shares in Q2 2026, an estimated $3.29K.
  • MML Investors Services first reported a position in Gossamer Bio in Q3 2025 and held it in 3 quarters.
  • MML Investors Services's Gossamer Bio position peaked at $32.1K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.